BR9507338A - Agente imunoterapêutico e seu uso - Google Patents

Agente imunoterapêutico e seu uso

Info

Publication number
BR9507338A
BR9507338A BR9507338A BR9507338A BR9507338A BR 9507338 A BR9507338 A BR 9507338A BR 9507338 A BR9507338 A BR 9507338A BR 9507338 A BR9507338 A BR 9507338A BR 9507338 A BR9507338 A BR 9507338A
Authority
BR
Brazil
Prior art keywords
immunotherapeutic agent
immunotherapeutic
agent
Prior art date
Application number
BR9507338A
Other languages
English (en)
Inventor
Graham Arthur William Rook
John Lawson Stanford
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of BR9507338A publication Critical patent/BR9507338A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9507338A 1994-03-30 1995-03-29 Agente imunoterapêutico e seu uso BR9507338A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9406301A GB9406301D0 (en) 1994-03-30 1994-03-30 Immunotherapeutic agent and its use
PCT/GB1995/000715 WO1995026742A1 (en) 1994-03-30 1995-03-29 Immunotherapeutic agent and its use

Publications (1)

Publication Number Publication Date
BR9507338A true BR9507338A (pt) 1997-09-16

Family

ID=10752750

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507338A BR9507338A (pt) 1994-03-30 1995-03-29 Agente imunoterapêutico e seu uso

Country Status (22)

Country Link
EP (1) EP0752870B1 (pt)
JP (1) JP4135190B2 (pt)
KR (1) KR100392582B1 (pt)
CN (1) CN1121874C (pt)
AP (1) AP9600861A0 (pt)
AT (1) ATE218355T1 (pt)
AU (1) AU699081B2 (pt)
BR (1) BR9507338A (pt)
CA (1) CA2186851C (pt)
CZ (1) CZ280196A3 (pt)
DE (1) DE69526935T2 (pt)
DK (1) DK0752870T3 (pt)
ES (1) ES2177638T3 (pt)
FI (1) FI111223B (pt)
GB (1) GB9406301D0 (pt)
HU (1) HU220858B1 (pt)
NO (1) NO964075L (pt)
NZ (1) NZ282863A (pt)
PT (1) PT752870E (pt)
RU (1) RU2139728C1 (pt)
WO (1) WO1995026742A1 (pt)
ZA (1) ZA952644B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
AU730548B2 (en) * 1996-12-18 2001-03-08 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the TH2 activity of the immune system
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
NZ581806A (en) * 2004-06-07 2011-10-28 Qu Biolog Inc Bacterial compositions for the treatment of cancer
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
BG66067B1 (bg) * 2005-05-18 2011-01-31 Спартак ХАДЖИЕВ Средство с антитуморна активност на база бцж ваксина, метод за неговото получаване и използването му
US8557257B2 (en) 2006-03-24 2013-10-15 Oncovac Inc. Mycobacterial immunotherapy for cancer treatment
EP3235506B1 (en) 2010-07-26 2023-12-06 Qu Biologics Inc. Immunogenic anti-inflammatory compositions
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
CN106456740B (zh) 2014-05-02 2021-06-08 Qu生物制药公司 抗微生物免疫调节
EP3319635B1 (en) * 2015-06-24 2021-04-21 Immodulon Therapeutics Limited A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions

Also Published As

Publication number Publication date
ATE218355T1 (de) 2002-06-15
AU2078595A (en) 1995-10-23
PT752870E (pt) 2002-09-30
ES2177638T3 (es) 2002-12-16
FI963866A (fi) 1996-09-27
KR100392582B1 (ko) 2003-10-30
GB9406301D0 (en) 1994-05-25
EP0752870A1 (en) 1997-01-15
AP9600861A0 (en) 1996-10-31
MX9604401A (es) 1997-12-31
FI963866A0 (fi) 1996-09-27
AU699081B2 (en) 1998-11-19
HU9602661D0 (en) 1996-11-28
DE69526935T2 (de) 2002-09-19
CZ280196A3 (en) 1997-02-12
DE69526935D1 (de) 2002-07-11
HUT75835A (en) 1997-05-28
JPH09511737A (ja) 1997-11-25
JP4135190B2 (ja) 2008-08-20
CA2186851A1 (en) 1995-10-12
CN1121874C (zh) 2003-09-24
RU2139728C1 (ru) 1999-10-20
CN1150388A (zh) 1997-05-21
NZ282863A (en) 2001-06-29
FI111223B (fi) 2003-06-30
KR970702057A (ko) 1997-05-13
ZA952644B (en) 1996-01-11
WO1995026742A1 (en) 1995-10-12
HU220858B1 (en) 2002-06-29
DK0752870T3 (da) 2002-07-15
NO964075L (no) 1996-11-25
EP0752870B1 (en) 2002-06-05
CA2186851C (en) 2008-11-18
NO964075D0 (no) 1996-09-27

Similar Documents

Publication Publication Date Title
BR9507338A (pt) Agente imunoterapêutico e seu uso
BR9509700A (pt) Diidropirimidina e seus usos
BR9703788A (pt) Sulfonamidas e seu uso
BR9601693A (pt) Composição e seus usos
MX9205496A (es) Agente dispersante
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
BR9711191A (pt) Composto e uso do mesmo
BR9708902A (pt) Derivados de benzofurila e seu uso
BR9506583A (pt) Composição cosmética e uso da mesma
BR9610109A (pt) Fecho e uso mesmo
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
BR9707812A (pt) Composto composto farmacêutica e uso do composto
BR9508264A (pt) Estrutura e artigo absorventes
BR9509651A (pt) Material superabsorvente e utilização do mesmo
BR9509650A (pt) Material superabsorvente e utilização do mesmo
BR9703378A (pt) Compostos de estilbeno e seu uso
KR970702861A (ko) 포르포시아닌 및 cnc-확장된 포르피린(porphocyanine and cnc-expanded porphyrins)
ID19147A (id) Ksilanase dan pemakaiannya
BR7401412U (pt) Estojo de uso pessoal
BR9509055A (pt) Imidazoloquinoxalinona uso da mesma e composiçao farmacêutica
BR9406460A (pt) Composição catalisadora e uso da mesma
NL1007839A1 (nl) Formulering en gebruik.
ITMI911146A0 (it) Agente antiarteriosclerotico, sua preparazione ed uso
FI944556A0 (fi) Foerfarande foer producering av antracykliner och deras mellanprodukter
FI944398A0 (fi) T-staengare i foenster

Legal Events

Date Code Title Description
PC Transfer

Free format text: STANFORD ROOK LIMITED (GB)

EG Technical examination (opinion): publication of technical examination (opinion)
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]